Close Menu
Home › Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business

Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business

Jan 09, 2019
|
Monica Heger

SAN FRANCISCO (GenomeWeb) – Adaptive Biotechnologies plans to become "the global leader" in immune profiling and designing customized therapeutics, according to CEO and Cofounder Chad Robins.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jun
17
Featured Webinar

Personal and Clinical Utility of Polygenic Risk Scores: A Review of the Evidence

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.

Jun
18
Featured Webinar

Clinical Genomics of NTRK Fusion Detection in Cancer

Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect. 

Jun
25
Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

What's Popular?

In Sequencing

  1. BGI Genomics Continues to Grow Clinical Testing Business, Add Partnerships

    Premium

  2. Metagenomic CSF Sequencing Improves Diagnosis of Neurological Infections, UCSF Study Finds

    Premium

  3. Saga Diagnostics Raises $4.2M

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.